LENSAR Inc (LNSR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $65.04M
Last updated: Nov 17, 2026 at 4:10 PM ET
LENSAR Inc (LNSR) Statistics
LENSAR (LNSR) has a market cap of $65.04M and an enterprise value of $54.29M. It kept 56.07% of revenue as net income over the last 12 months. It holds $10.75M more cash than debt, 16.52% of its market cap.
Total Valuation
Enterprise value is 16.52% below the market cap, as cash exceeds debt.
| Market Cap | $65.04M |
|---|---|
| Enterprise Value | $54.29M |
| Latest price (Nov 17, 2026) | $4.91 |
Key Dates
The next earnings report is expected on Feb 25, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 25, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.0x and 5.5x. Its year-end P/S ranged from 0.9x to 2.4x from 2020 to 2025.
| P/S Ratio | 1.0x |
|---|---|
| Forward P/S | 1.1x |
| P/B Ratio | 5.5x |
| P/TBV Ratio | 9.3x |
Enterprise Valuation
Counting debt and cash, the company is valued at 1.8x EBITDA.
| EV / Earnings | 1.6x |
|---|---|
| EV / Sales | 0.9x |
| EV / EBITDA | 1.8x |
Price Statistics
The stock is down 51.43% over 52 weeks and trades 21.94% below its 50-day average.
| Beta (1Y) | 0.62 |
|---|---|
| 52-Week Change | -51.43% |
| 1-Month Change | -14.61% |
| 3-Month Change | -43.69% |
| 6-Month Change | -15.34% |
| 5-Year Change | -18.32% |
| Total Return (1Y) | -51.43% |
| Total Return (3Y CAGR) | +30.87% |
| Total Return (5Y CAGR) | -7.14% |
| Return vs SPY (1Y) | -62.31% |
| Max Drawdown (1Y) | -64.02% |
| Max Drawdown (3Y) | -72.85% |
| Sharpe Ratio (1Y) | -0.99 |
| Correlation with SPY (1Y) | 0.12 |
| 50-Day Average | $6.29 |
| 200-Day Average | $7.02 |
| 52-Week Range | $4.30 to $12.94 |
| RSI (14 Days) | 36.1 |
| Average Volume (20 Days) | 74.54K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.25x current liabilities, and total debt is 0.17x shareholder equity.
| Current Ratio | 2.25x |
|---|---|
| Quick Ratio | 0.98x |
| Debt / Equity | 0.17x |
| Debt / EBITDA | 0.07x |
Returns and Efficiency
Return on invested capital is 142.16% over the last 12 months, against a 5-year average of 106.01%.
| Return on Equity (ROE) | 304.38% |
|---|---|
| Return on Assets (ROA) | 50.23% |
| Return on Invested Capital (ROIC) | 142.16% |
| ROA (5Y Average) | -36.24% |
| ROIC (5Y Average) | 106.01% |
| Asset Turnover | 0.88x |
| Inventory Turnover | 1.15x |
| Receivables Turnover | 10.63x |
| Cash Conversion Cycle | 218 days |
Scores
LNSR has an Altman Z-Score of 0.38, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.38 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $60.08M over the last 12 months is up 1.59% from the 12 months before.
| Revenue | $60.08M |
|---|---|
| Revenue Growth (YoY) | +1.59% |
| Gross Profit | $31.26M |
| Operating Income | -$1.98M |
| Pretax Income | $33.29M |
| Net Income | $33.69M |
| Reported EPS (TTM) | -$0.33 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 16.51% of the $67.07M in total assets.
| Cash and Equivalents | $12.62M |
|---|---|
| Total Debt | $1.88M |
| Net Cash | $10.75M |
| Net Cash Per Share | $0.87 |
| Working Capital | $24.68M |
| Shareholder Equity | $11.07M |
| Book Value Per Share | $0.89 |
| Tangible Book Value | $6.56M |
| Tangible Book Per Share | $0.53 |
| Total Assets | $67.07M |
| Total Liabilities | $42.22M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $147.00K of capital spending, operating cash flow left -$4.79M of free cash flow.
| Operating Cash Flow | -$4.65M |
|---|---|
| Capital Expenditures | $147.00K |
| Free Cash Flow | -$4.79M |
| FCF Per Share | -$0.39 |
| Depreciation and Amortization | $4.47M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -3.29%, against a 5-year average of -41.02%.
| Gross Margin | 52.03% |
|---|---|
| Operating Margin | -3.29% |
| Pretax Margin | 55.41% |
| Net Margin | 56.07% |
| FCF Margin | -7.98% |
| Gross Margin (5Y Average) | 50.60% |
| Operating Margin (5Y Average) | -41.02% |
| Net Margin (5Y Average) | -52.94% |
Growth
Revenue grew 18.23% a year over 3 years.
| Revenue Growth (3Y CAGR) | +18.23% |
|---|---|
| Revenue Growth (5Y CAGR) | +17.24% |
Dividends and Yields
LNSR does not pay a dividend.
| Buyback Yield | -0.68% |
|---|---|
| Shareholder Yield | -0.68% |
Peer Position
Against 11 similar companies, LNSR has the 8th highest P/S.
P/S RatioPeer median 2.2x
ROICPeer median -58.52%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.32%
| P/S Ratio | 1.0x vs 2.2x median |
|---|---|
| ROIC | 142.16% vs -58.52% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +1.59% vs +6.32% median |
Analyst Forecast
Consensus estimates put revenue growth at 11.55% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +11.55% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About LNSR
What is LNSR's market cap?
LENSAR has a market cap of $65.04M. Its enterprise value, which adds debt and subtracts cash, is $54.29M.
How many shares of LNSR are outstanding?
LENSAR has 12.40M shares outstanding. The count is up 2.94% from a year earlier.
Does LNSR pay a dividend?
No. LENSAR does not pay a dividend.
How much debt does LNSR have?
LENSAR has $1.88M of total debt and $12.62M of cash and equivalents, a net cash position of $10.75M.
LNSR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors